ArticleCell cycle (Georgetown, Tex.)2018

Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Kei Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.